1. Home
  2. |Insights
  3. |Crowell & Moring Partners Juan A. Arteaga and Michael W. Lieberman Named Law360 2017 "Rising Stars"

Crowell & Moring Partners Juan A. Arteaga and Michael W. Lieberman Named Law360 2017 "Rising Stars"

Firm News | 4 min read | 08.10.17

Named Respectively in the Antitrust and Health Care Categories

Washington – August 10, 2017: Crowell & Moring is pleased to announce that Juan A. Arteaga, a partner in the firm’s Antitrust Group in New York, and Michael W. Lieberman, a partner in the firm’s Health Care, Commercial Litigation, and White Collar & Regulatory Enforcement groups in Washington, have been named to Law360’s 2017 “Rising Stars” list. The list features lawyers under age 40 who have demonstrated outstanding career accomplishments.

Arteaga, who joined Crowell & Moring in July 2017 after serving as a Deputy Assistant Attorney General in the U.S. Department of Justice’s Antitrust Division, was recognized for his work at DOJ investigating and challenging numerous multibillion-dollar merger deals during his time. Law360 noted his role in Anheuser-Busch InBev’s $107 acquisition of SABMiller, which Arteaga said was one of the first major investigations he handled as a Deputy Assistant Attorney General.

Arteaga told Law360 that antitrust law’s intersection of transactions and litigation attracted him to the field. “One moment you can be counseling a client on the risks associated with a certain deal and how to minimize those risks,” he said. “Another moment you can be in court defending a client’s transaction or business practices.” Click here to read Arteaga’s Rising Star profile.

Lieberman, whose first job after law school was as an associate at Crowell & Moring, was recognized for his role in complex health care litigation, including the ongoing defense of eight Blue Cross Blue Shield plans in a massive multidistrict litigation antitrust case.

Lieberman told Law360 that he is motivated by the trust his clients place in him to help solve their problems and that he is particularly drawn to the complexity and changing nature of health care litigation. Lieberman emphasized that he takes his work home with him, both in thinking about cases and making himself available to clients. “I think to do the job well, my clients count on me to be available and give my best advice. And I think they are best served when I am thinking about the case with the same regularity and seriousness as they are,” he said.  Click here to read Lieberman’s Rising Star profile.

Law360 editors evaluated nominations about more than 1,200 lawyers in recognizing 156 practitioners across more than 40 practice categories. Click here to view the complete list of 2017 Rising Stars.

No aspect of this advertisement has been approved by the Bars of, or any courts in, the jurisdictions in which the lawyers are admitted to practice.

About Crowell & Moring’s Antitrust Group

Crowell & Moring's Antitrust Group is recognized as one of the leading practices in the United States and around the world. Clients engage the firm to help navigate their most complex competition law issues, including: international merger control; private damages actions; cartel investigations and litigation; government investigations; and counseling and compliance. The group’s approximately 80 lawyers routinely represent industry-leading companies in some of the largest and most complex mergers and acquisitions in recent history – including successful DOJ clearance of AT&T’s $67 billion acquisition of DIRECTV, one of the 20 largest transactions of all time – as well as in both affirmative recovery and defense-side antitrust litigation. The firm’s antitrust litigators have achieved major results, including ongoing defense of United Airlines, DuPont, CSX, leading health care distributor Owens & Minor, and Blue Cross plans, as well as the recovery of more than a billion dollars for antitrust clients including Oracle, General Motors, and Motorola.  

About Crowell & Moring’s Health Care Group

Crowell & Moring's nationally recognized Health Care Group provides a comprehensive range of litigation, investigation, regulatory compliance, fraud and abuse, transactions and counseling services to health care clients nationwide. Our clients include payers (including the top 10 national health insurers), hospitals and hospital systems, medical groups and medical group managers, pharmaceutical companies, pharmacy benefit managers, academic medical centers, government contractors, as well as established and start-up medical device and biotech companies. Our clients rely on Crowell & Moring's experience and interdisciplinary approach to provide strategic solutions to their complex legal challenges. The group publishes the C&M Health Law Blog, which includes analysis, commentary, and the latest developments in health care law and policy. Follow the group on Twitter at @CMHealthCareLaw.

About Crowell & Moring LLP

Crowell & Moring LLP is an international law firm with approximately 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, DC, New York, Los Angeles, San Francisco, Orange County, London, and Brussels.

Insights

Firm News | 1 min read | 11.22.24

Crowell & Moring Represents Anitian in Successful $7M Series D Funding

San Francisco - November 22, 2024: Crowell & Moring advised Anitian, a leading provider of compliance automation solutions, on a $7 million Series D funding, led by Sageview Capital and with participation by Forgepoint Capital. This funding enables Anitian to accelerate the development of new innovations, including AI-driven automation features and an accredited Platform-as-a-Service (PaaS). Together, these features reduce the time and cost of achieving FedRAMP and CMMC compliance for Cloud Service Providers (CSPs) and the Defense Industrial Base (DIB). The most recent financing brings Anitian’s total funding to more than $50 million....